HIF-PHIs associated with embolic and thrombotic events: a real-world pharmacovigilance study based on the Japan Adverse Drug Event Report database

Background Hypoxia-inducible factor prolyl hydroxylase inhibitors (HIF-PHIs) play an important role in the treatment of renal anemia. However, some studies suggest a potential link between HIF-PHIs and increased thrombosis risk, though these findings are inconsistent and lack large-scale clinical su...

詳細記述

書誌詳細

出版年:	Renal Failure
主要な著者:	Danna Wu, Shuxin Jiao, Hongru Lin, Peitao Xie, Guohao Cai, Mingdao Lin
フォーマット:	論文
言語:	英語
出版事項:	Taylor & Francis Group 2025-12-01
主題:	Hypoxia-inducible factor prolyl hydroxylase inhibitors renal anemia embolic and thrombotic events JADER
オンライン･アクセス:	https://www.tandfonline.com/doi/10.1080/0886022X.2025.2491655